488 related articles for article (PubMed ID: 34435935)
1. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
Cohen OG; Clark AK; Milbar H; Tarlow M
Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935
[TBL] [Abstract][Full Text] [Related]
2. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
Valk B; Bender B
Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
[TBL] [Abstract][Full Text] [Related]
3. Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl.
Bin Rubaian NF; Almuhaidib SR; Aljarri SA; Alamri AS
Cureus; 2022 Jul; 14(7):e27108. PubMed ID: 36004038
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study.
Cebeci Kahraman F; Savaş Erdoğan S; Aktaş ND; Albayrak H; Türkmen D; Borlu M; Arıca DA; Demirbaş A; Akbayrak A; Polat Ekinci A; Gökçek GE; Çelik HA; Taşolar MK; An İ; Temiz SA; Hazinedar E; Ayhan E; Hızlı P; Solak EÖ; Kılıç A; Yılmaz E
J Cosmet Dermatol; 2022 Sep; 21(9):3692-3703. PubMed ID: 35780311
[TBL] [Abstract][Full Text] [Related]
5. Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.
Carballido Vázquez AM; Morgado B
Br J Dermatol; 2021 Aug; 185(2):e34. PubMed ID: 33904157
[No Abstract] [Full Text] [Related]
6. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
Buckley JE; Landis LN; Rapini RP
JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062
[TBL] [Abstract][Full Text] [Related]
7. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
Cyrenne BM; Al-Mohammedi F; DeKoven JG; Alhusayen R
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e546-e548. PubMed ID: 33982814
[No Abstract] [Full Text] [Related]
8. Pityriasis Rosea after COVID-19 Infection.
Prtajin M; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
[TBL] [Abstract][Full Text] [Related]
9. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
Pedrazini MC; da Silva MH
Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265
[TBL] [Abstract][Full Text] [Related]
10. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.
Birlutiu V; Birlutiu RM; Iancu GM
Medicine (Baltimore); 2021 Apr; 100(14):e25352. PubMed ID: 33832113
[TBL] [Abstract][Full Text] [Related]
11. A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
Wong N; Cascardo CA; Mansour M; Qian V; Potts GA
Cureus; 2023 May; 15(5):e38772. PubMed ID: 37303403
[TBL] [Abstract][Full Text] [Related]
12. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
Drago F; Broccolo F; Ciccarese G
Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
[TBL] [Abstract][Full Text] [Related]
13. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
[TBL] [Abstract][Full Text] [Related]
14. Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.
Hunjan MK; Roberts C; Karim S; Hague J
Clin Exp Dermatol; 2022 Jan; 47(1):188-190. PubMed ID: 34379821
[TBL] [Abstract][Full Text] [Related]
15. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
Wang CS; Chen HH; Liu SH
J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
[TBL] [Abstract][Full Text] [Related]
16. Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2.
Ramot Y; Nanova K; Faitatziadou SM; Assab DA; Berkun Y; Zlotogorski A
J Dtsch Dermatol Ges; 2022 Aug; 20(8):1123-1124. PubMed ID: 35698860
[No Abstract] [Full Text] [Related]
17. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
[TBL] [Abstract][Full Text] [Related]
18. Pityriasis lichenoides chronica after BNT162b2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV-2 vaccine.
Drago F; Ciccarese G; Guadagno A; Parodi A
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e979-e981. PubMed ID: 35841285
[No Abstract] [Full Text] [Related]
19. Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine.
Marghalani S; Alghamdi Y; Albrakati BA; Huwait HF; Mohanna AT
Cureus; 2024 Mar; 16(3):e56310. PubMed ID: 38628985
[TBL] [Abstract][Full Text] [Related]
20. Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman.
Al Hatmi I; Al Maqbali H; Al Waily A; Al Khalili A; Qureshi A
Oman Med J; 2023 Nov; 38(6):e579. PubMed ID: 38264510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
